Robotic Versus Thoracolaparoscopic Esophagectomy for Esophageal Cancer

GEM Hospital & Research Center

Status: Unknown

Conditions: Esophageal Cancer

Treatments: Procedure: Robotic esophagectomy; Procedure: Thoracolaparoscopic esophagectomy

Study type: Interventional

Funder types: Other

Identifiers

NCT03727126

GEMBOT

Details and patient eligibility

About

Esophageal cancer is a debilitating condition. The treatment involved is complex requiring a combination of chemotherapy and surgery in most cases. Complete removal of the tumor and the adjacent lymph nodes is of utmost importance in improving the survival. Lymph node yield following surgery helps in proper staging of the disease and is an important prognosticating variable. It is hypothesized that the lymph node yield following robotic esophagectomy is higher than that following thoracolaparoscopic esophagectomy. The study aims to compare the short term oncological outcomes following robotic esophagectomy and thoracolaparoscopic esophagectomy for carcinoma esophagus.

Enrollment: 40 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Resectable esophageal carcinoma, either squamous cell carcinoma or adenocarcinoma in the middle or lower part the esophagus

Exclusion criteria

• American Society of Anesthesiologists (ASA) class 4 and above
• Esophagectomy for other non-malignant conditions

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

40 participants in 2 patient groups

Robotic esophagectomy

Experimental group

Description:

Esophagectomy performed for esophageal cancer using the da Vinci robotic surgical system

Treatment:

Procedure: Robotic esophagectomy

Thoracolaparoscopic esophagectomy

Active Comparator group

Description:

Esophagectomy performed for esophageal cancer using conventional thoracoscopic and laparoscopic techniques

Treatment:

Procedure: Thoracolaparoscopic esophagectomy